Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Magnetic Resonance Imaging
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Chronic Pain
1 trial -
Pregabalin
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Abuse
1 trial -
Preoperative Genotyping
BRIGHT MINDS BIOSCIENCES INC.
PPAP
1 trial -
Probiotics
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Progesterone
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Cessation
1 trial -
Progesterone
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Abuse
2 trials -
Progesterone
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Cessation
1 trial -
RT-PCR Test
BRIGHT MINDS BIOSCIENCES INC.
COVID-19
1 trial -
Reduced Nicotine Content Cigarettes
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Dependence
2 trials -
Rehabilitation Therapy as part of Standard of Care (Control)
BRIGHT MINDS BIOSCIENCES INC.
Acute Stroke
1 trial -
Sarcosine
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
1 trial -
Seromycin (D-cycloserine, DCS)
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Addiction
1 trial -
Single dose of ibuprofen (800 mg tablet)
BRIGHT MINDS BIOSCIENCES INC.
Human Gastrointestinal Physiology Data
1 trial -
Standard of Care medication for early Alzheimer's Disease
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer Disease
1 trial -
Study Agent
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
Tolcapone
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Transdermal nicotine patch
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
Very Low Nicotine Cigarette
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use
1 trial -
Very low nicotine cigarettes
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Vitamin D supplement
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Within-subjects (MDMA)
BRIGHT MINDS BIOSCIENCES INC.
Drug Addiction
1 trial -
active nicotine gum
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
cocaine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources